A Novel Homogeneous β-Galactosidase Immunoassay System
A new generation of enzyme immunoassays (EIAs) that offer better accuracy is now possible with the help of recombinant DNA techniques. The use of fragmented β-galactosidase proteins obtained from genetically engineered Escherichia coli forms the basis of this new concept in EIAs. Traditionally, EIAs have been performed using whole enzyme molecules covalently linked to an antibody, an antigen, or a hapten, as described elsewhere (Monroe, 1983, 1984, 1985). Assay speed and precision are often compromised with conventional methods, however, owing to required sample pretreatment, incubation, and washing steps. Such tedious procedures can now be eliminated by means of this new separation-free or homogeneous β-galactosidase immunoassay system known as CEDIA™ (Henderson et al., 1986).
KeywordsTetrameric Enzyme Enzyme Peptide Sodium Potassium Phosphate Homogeneous Immunoassay Enzyme Donor
Unable to display preview. Download preview PDF.
- Davis, R. W., Botstein, D. and Roth, J. R. (1980). In A Manual for Genetic Engineering, Advanced Bacterial Genetics, Cold Spring Harbor Laboratory, New York, p. 250.Google Scholar
- Monroe, D. (1983). ELISA: a versatile chemical tool. American Clinical Products Review, 2(3), 22–27.Google Scholar
- Monroe, D. (1984). Enzyme immunoassay. Anal. Chem., 56(8), 921A–931A.Google Scholar
- Monroe, D. (1985). The solid-phase enzyme-linked immunospot assay: current and potential applications. Biotechniques, 3(3), 222–229.Google Scholar